Free Trial

Wolff Wiese Magana LLC Sells 601 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background

Wolff Wiese Magana LLC lowered its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 54.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 506 shares of the semiconductor company's stock after selling 601 shares during the period. Wolff Wiese Magana LLC's holdings in Synopsys were worth $246,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Pacifica Partners Inc. bought a new position in Synopsys during the third quarter valued at $25,000. Kieckhefer Group LLC bought a new position in shares of Synopsys in the fourth quarter worth $27,000. Tsfg LLC grew its position in shares of Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company's stock valued at $28,000 after purchasing an additional 24 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in Synopsys by 40.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company's stock worth $35,000 after purchasing an additional 20 shares in the last quarter. Finally, Fairscale Capital LLC purchased a new position in Synopsys during the 2nd quarter valued at about $51,000. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Up 2.4 %

NASDAQ SNPS opened at $501.97 on Wednesday. The stock's 50 day moving average is $522.21 and its 200 day moving average is $527.43. The firm has a market capitalization of $77.59 billion, a PE ratio of 34.57, a P/E/G ratio of 3.41 and a beta of 1.12. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SNPS. Needham & Company LLC reiterated a "buy" rating and issued a $640.00 price objective on shares of Synopsys in a research report on Thursday, December 5th. Mizuho started coverage on shares of Synopsys in a research note on Tuesday, October 22nd. They issued an "outperform" rating and a $650.00 target price on the stock. Rosenblatt Securities reissued a "buy" rating and issued a $635.00 price target on shares of Synopsys in a report on Wednesday, December 4th. Wells Fargo & Company cut their target price on shares of Synopsys from $570.00 to $540.00 and set an "equal weight" rating for the company in a research report on Monday. Finally, Redburn Atlantic assumed coverage on Synopsys in a research note on Monday. They set a "buy" rating and a $600.00 price target for the company. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $641.82.

View Our Latest Stock Analysis on SNPS

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Recent Videos

Affordable AI Stocks: 7 Picks Under $50
2025 Natural Gas Comeback: 3 Stocks Poised for Big Gains
Why the Latest Jobs Data Has Wall Street Nervous

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines